Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) - Global Forecast to 2028
Report Code: BT 8892 Dec, 2023, by marketsandmarkets.com
The tissue engineering market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.9 billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of the tissue engineering market is largely driven by the emergence of promising technologies, including 3D bioprinting, and rising demand for advanced solutions for damaged tissue repair and regeneration.
Tissue Engineering Market - Global Forecast to 2028
To know about the assumptions considered for the study, Request for Free Sample Report
Attractive Opportunities in the Tissue Engineering Market
Global Tissue Engineering Market Dynamics
Driver: Growing need for regenerative medicines
The increasing demand for advanced regenerative medicines for the treatment of chronic and degenerative diseases is accelerating the growth of the tissue engineering market. The rising rate of degenerative diseases and increasing incidences of road accidents are promoting the demand for regenerative medicines, resulting in the growth of the tissue engineering market. For instance, according to the Centers for Disease Control and Prevention (CDC) in the United States, each day, around 190 people died from Traumatic Brain Injury (TBI) in 2021. In addition, according to the CDC, every year, around 1.35 million individuals die in road accidents worldwide.
Restraint: High treatment cost
The advanced tissue engineering technologies used for the treatment of chronic and degenerative disorders are expensive. The tissue engineered products are associated with high quality biomaterials, growth factors, living cells, scaffolds, and functional matrices. Therefore, tissue engineering therapy is expensive. Thus, high treatment costs are hampering the growth of the tissue engineering market.
Opportunity: Increasing technological advancements such as 3D printing and Quantum Magnetic Resonance Therapy (QMRT)
The various technological developments in the field of tissue engineering including 3D printing, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT), are expected to promote the growth of the tissue engineering market. For instance, Cytotron, a therapeutic device associated with Quantum Magnetic Resonance Therapy (QMRT) is used for the treatment of cancer as well as orthopedic diseases. The therapy is used for tissue degeneration in cancer and tissue regrowth in musculoskeletal diseases.
Challenge: Cost effective traditional organ transplant techniques
Organ transplantation technique is the medical process of removal of organs or tissue from the human body and surgically transplanted into recipients. The organ transplantation technique is quite cost-effective as compared to the technologically advanced tissue engineering therapy. Therefore, the cost effectiveness of traditional organ transplant techniques can be one of the major challenging factors for the growth of the tissue engineering market.
Global Tissue Engineering Market Ecosystem Analysis
The ecosystem of tissue engineering consists of end users from hospitals, specialty clinics, ambulatory surgical centers, transplant centers, tissue engineering product and service providers, technology providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of tissue engineering products, enhance drug discovery processes, and develop new therapeutics.
The scaffold segment is expected to register the fastest growth in tissue engineering industry during the forecast period.
Based on the product type of tissue engineering, the market has been segmented into scaffolds, tissue grafts, and other products. In 2022, scaffold segment accounted for the largest share and is expected to grow during the forecast period. The scaffold segment's dominance is due to the booming healthcare industry and increasing technological developments in regenerative medicines.
Orthopedics and musculoskeletal disorders held a dominant share in the application segment in the tissue engineering industry.
Based on the application, the tissue engineering market has been segmented into orthopedics & musculoskeletal disorders, dental disorders, cardiovascular diseases, dermatology & wound care, and others. In 2022, orthopedics & musculoskeletal disorders hold the largest share of the tissue engineering market due to the increasing rate of road accidents and rising incidences of chronic disorders. The increasing rate of road accidents drives the demand for innovative tissue regeneration solutions to repair and reconstruct damaged tissues.
North America accounted for the largest share of the tissue engineering industry in 2022.
To know about the assumptions considered for the study, download the pdf brochure
Geographically, the tissue engineering market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the dominant share followed by Europe. The booming healthcare sector and growing research activities in the tissue engineering field are the major factors for the dominance of the North American region in the tissue engineering market. Additionally, the increasing rate of degenerative diseases is promoting the growth of the tissue engineering market in the North American region.
Key players in the global tissue engineering market include Organogenesis (US), AbbVie Inc. (US), Baxter (US), BD (US), B. Braun (Germany), TEIJIN Limited (Japan), Institut Straumann AG (Switzerland), Integra Lifesciences (US), Johnson & Johnson Services, Inc. (US), Medtronic (Ireland), NuVasive, Inc. (US), Stryker (US), Terumo Corporation (Japan), W. L. Gore & Associates Inc. (US), Zimmer Biomet (US), Smith & Nephew plc (UK), MIMEDX Group, Inc. (US), BioTissue (US), CollPlant Biotechnologies Ltd. (Israel), Sumitomo Pharma Co., Ltd. (Japan), Matricel GmbH (Germany), Mallinckrodt (US), Regrow Biosciences Pvt Ltd (India), Vericel Corporation (US), Tecnoss S.R.L. (Italy), Tegoscience (South Korea), and Tissue Regenix (UK).
Scope of the Tissue Engineering Industry
|
Report Metric |
Details |
|
Market Revenue in 2023 |
$4.4 billion |
|
Projected Revenue by 2028 |
$8.9 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 15.3% |
|
Market Driver |
Growing need for regenerative medicines |
|
Market Opportunity |
Increasing technological advancements such as 3D printing and Quantum Magnetic Resonance Therapy (QMRT) |
This report categorizes the tissue engineering market to forecast revenue and analyze trends in each of the following submarkets:
By Product Type
-
Scaffold, By Material
- Synthetic Material
-
Biological Material
- Collagen
- Hydrogel
- Stem Cells
- Others
-
Tissue Grafts, By Type
- Allograft
- Autograft
- Synthetic Grafts
- Xenograft
- Other Products
By Material
- Synthetic Material
- Biologically Derived Material
By Application
- Orthopedics & Musculoskeletal Disorders
- Dermatology & Wound Care
- Dental Disorders
- Cardiovascular Diseases
- Others
By End User
- Hospitals
- Specialty Centers and Clinics
- Ambulatory Surgical Centers
By Region
-
North America
- US
- Canada
-
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- Japan
- China
- India
- South Korea
- Rest of Asia Pacific (RoAPAC)
-
Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa
- Middle East
- Africa
Recent Developments of Tissue Engineering Industry
- In September 2023, MIMEDX Group Inc. launched EPIEFFECT to broaden its advanced wound care product portfolio. EPIEFFECT is a lyophilized human placental-based allograft consisting of amnion and chorion membranes.
- In July 2023, Teijin Limited launched SYNFOLIUM, a cardiovascular surgical patch and received manufacturing and marketing approval in Japan. The cardiovascular surgical patch is used for the surgical treatment of congenital heart disease (CHD).
- In July 2021, Integra Lifesciences introduced SurgiMend, a collagen matrix. The product is used for soft tissue repair and reconstruction.
- In May 2020, AbbVie Inc. (US) acquired Allergan plc (Ireland) to expand the product portfolio in therapeutics categories. Allergan plc provides new growth opportunities to AbbVie Inc. in neuroscience with Vraylar, Botox therapeutics, and global aesthetics business.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global tissue engineering market?
The global tissue engineering market boasts a total revenue value of $8.9 billion by 2028.
What is the estimated growth rate (CAGR) of the global tissue engineering market?
The global tissue engineering market has an estimated compound annual growth rate (CAGR) of 15.3% and a revenue size in the region of $4.4 billion in 2023.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 45)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 50)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 TISSUE ENGINEERING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 TISSUE ENGINEERING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF ABBVIE INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 8 TISSUE ENGINEERING MARKET: CAGR PROJECTIONS
FIGURE 9 TISSUE ENGINEERING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY (Page No. - 62)
FIGURE 11 TISSUE ENGINEERING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 TISSUE ENGINEERING MARKET, BY MATERIAL, 2023 VS. 2028 (USD MILLION)
FIGURE 13 TISSUE ENGINEERING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 TISSUE ENGINEERING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF TISSUE ENGINEERING MARKET
4 PREMIUM INSIGHTS (Page No. - 66)
4.1 TISSUE ENGINEERING MARKET OVERVIEW
FIGURE 16 GROWING DEMAND FOR REGENERATIVE MEDICINE TO DRIVE MARKET
4.2 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY MATERIAL AND COUNTRY (2022)
FIGURE 17 SYNTHETIC MATERIALS HELD LARGEST SHARE OF ASIA PACIFIC TISSUE ENGINEERING MARKET IN 2022
4.3 TISSUE ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 INDIA TO WITNESS HIGHEST GROWTH IN TISSUE ENGINEERING MARKET DURING FORECAST PERIOD
4.4 TISSUE ENGINEERING MARKET SHARE, BY PRODUCT, 2022
FIGURE 19 SCAFFOLDS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
5 MARKET OVERVIEW (Page No. - 69)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 TISSUE ENGINEERING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 TISSUE ENGINEERING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for regenerative medicine
5.2.1.2 Ongoing clinical trials and approvals in tissue engineering field
TABLE 5 ONGOING TISSUE ENGINEERING PRODUCT TRIALS REGISTERED ON CLINICALTRIALS.GOV
TABLE 6 EUROPE: TISSUE ENGINEERING PRODUCT TRIALS, JANUARY 2009–DECEMBER 2021
5.2.1.3 Availability of funding and investments for research and development of tissue engineering products
5.2.2 RESTRAINTS
5.2.2.1 High treatment cost
5.2.2.2 Complex regulatory process
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Technological advancements in tissue engineering products
5.2.4 CHALLENGES
5.2.4.1 Cost-effective traditional organ transplant technique
5.2.4.2 Limited awareness
5.2.4.3 Safety concerns and complexity of biomaterials
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 21 REVENUE SHIFT AND NEW POCKETS FOR TISSUE ENGINEERING PRODUCT PROVIDERS
5.4 PRICING ANALYSIS
TABLE 7 AVERAGE PRICE OF TISSUE ENGINEERING PRODUCTS, BY COMPANY, 2022
TABLE 8 AVERAGE PRICE OF TISSUE ENGINEERING PRODUCTS, BY REGION, 2022
5.5 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF TISSUE ENGINEERING MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 23 TISSUE ENGINEERING MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
TABLE 9 ECOSYSTEM FOR TISSUE ENGINEERING
5.8 TECHNOLOGY ANALYSIS
5.9 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS FOR TISSUE ENGINEERING MARKET, JANUARY 2013–OCTOBER 2023
TABLE 10 INDICATIVE LIST OF PATENTS IN TISSUE ENGINEERING MARKET
5.10 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 11 TISSUE ENGINEERING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 16 TISSUE ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TISSUE ENGINEERING PRODUCTS
5.13.2 BUYING CRITERIA FOR TISSUE ENGINEERING PRODUCTS
FIGURE 26 KEY BUYING CRITERIA FOR END USERS
6 TISSUE ENGINEERING MARKET, BY PRODUCT (Page No. - 94)
6.1 INTRODUCTION
TABLE 17 TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 SCAFFOLDS
TABLE 18 SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA: SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1 SYNTHETIC SCAFFOLDS
6.2.1.1 Controlled degradation rate and ability to design specific microarchitecture to drive adoption
TABLE 25 SYNTHETIC SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: SYNTHETIC SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 EUROPE: SYNTHETIC SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: SYNTHETIC SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 LATIN AMERICA: SYNTHETIC SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA: SYNTHETIC SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 BIOLOGICAL SCAFFOLDS
TABLE 31 BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 32 BIOLOGICAL SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: BIOLOGICAL SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: BIOLOGICAL SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: BIOLOGICAL SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 LATIN AMERICA: BIOLOGICAL SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: BIOLOGICAL SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2.1 Collagen-based scaffolds
6.2.2.1.1 Rising demand for advanced tissue regeneration solutions to drive market
TABLE 38 COLLAGEN-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: COLLAGEN-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: COLLAGEN-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: COLLAGEN-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 LATIN AMERICA: COLLAGEN-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: COLLAGEN-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2.2 Hydrogel-based scaffolds
6.2.2.2.1 Low mechanical strength of hydrogels to hamper adoption
TABLE 44 HYDROGEL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: HYDROGEL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 EUROPE: HYDROGEL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: HYDROGEL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 LATIN AMERICA: HYDROGEL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA: HYDROGEL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2.3 Stem cell-based scaffolds
6.2.2.3.1 Growing adoption of stem cell-based scaffolds for wound healing to drive market
TABLE 50 STEM CELL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: STEM CELL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: STEM CELL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: STEM CELL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: STEM CELL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA: STEM CELL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2.4 Other biological material-based scaffolds
TABLE 56 OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 EUROPE: OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 LATIN AMERICA: OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA: OTHER BIOLOGICAL MATERIAL-BASED SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 TISSUE GRAFTS
TABLE 62 TISSUE GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 TISSUE GRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: TISSUE GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: TISSUE GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: TISSUE GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 LATIN AMERICA: TISSUE GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA: TISSUE GRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 ALLOGRAFTS
6.3.1.1 Risk of donor-to-recipient disease transmission to restrict market growth
TABLE 69 ALLOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 70 NORTH AMERICA: ALLOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 EUROPE: ALLOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: ALLOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 LATIN AMERICA: ALLOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA: ALLOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 AUTOGRAFTS
6.3.2.1 Advancements in tissue processing techniques to support market growth
TABLE 75 AUTOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: AUTOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 EUROPE: AUTOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 ASIA PACIFIC: AUTOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 LATIN AMERICA: AUTOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 MIDDLE EAST & AFRICA: AUTOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 SYNTHETIC GRAFTS
6.3.3.1 Continuous innovations in materials science and engineering to drive market
TABLE 81 SYNTHETIC GRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: SYNTHETIC GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: SYNTHETIC GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: SYNTHETIC GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: SYNTHETIC GRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 MIDDLE EAST & AFRICA: SYNTHETIC GRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 XENOGRAFTS
6.3.4.1 Growing R&D activities to propel market
TABLE 87 XENOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: XENOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: XENOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: XENOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 LATIN AMERICA: XENOGRAFTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: XENOGRAFTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 OTHER PRODUCTS
TABLE 93 OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 LATIN AMERICA: OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: OTHER TISSUE ENGINEERING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 TISSUE ENGINEERING MARKET, BY MATERIAL (Page No. - 135)
7.1 INTRODUCTION
TABLE 99 TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
7.2 SYNTHETIC MATERIALS
7.2.1 ADVANCEMENTS IN SCAFFOLD PREPARATION TECHNIQUES TO SUPPORT MARKET GROWTH
TABLE 100 TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 101 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 EUROPE: TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR SYNTHETIC MATERIALS, BY REGION, 2021–2028 (USD MILLION)
7.3 BIOLOGICALLY DERIVED MATERIALS
7.3.1 INCREASING DEMAND FOR NATURAL MATERIALS TO DRIVE MARKET
TABLE 106 TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 107 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY REGION, 2021–2028 (USD MILLION)
8 TISSUE ENGINEERING MARKET, BY APPLICATION (Page No. - 144)
8.1 INTRODUCTION
TABLE 112 TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS
8.2.1 INCREASING INCIDENCE OF ORTHOPEDIC AND MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
TABLE 113 TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL DISORDERS, BY REGION, 2021–2028 (USD MILLION)
8.3 DERMATOLOGY & WOUND CARE
8.3.1 GROWING NUMBER OF ROAD ACCIDENTS TO AID MARKET GROWTH
TABLE 119 TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR DERMATOLOGY & WOUND CARE, BY REGION, 2021–2028 (USD MILLION)
8.4 DENTAL DISORDERS
8.4.1 INCREASING PREVALENCE OF DENTAL DISORDERS TO PROPEL MARKET
TABLE 125 TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 126 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 EUROPE: TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR DENTAL DISORDERS, BY REGION, 2021–2028 (USD MILLION)
8.5 CARDIOVASCULAR DISEASES
8.5.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
TABLE 131 TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 132 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 EUROPE: TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 135 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
8.6 OTHER APPLICATIONS
TABLE 137 TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 138 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 EUROPE: TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 140 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 141 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9 TISSUE ENGINEERING MARKET, BY END USER (Page No. - 162)
9.1 INTRODUCTION
TABLE 143 TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS
9.2.1 RISING ADOPTION OF REGENERATIVE MEDICINE IN DEVELOPING COUNTRIES TO DRIVE MARKET
TABLE 144 TISSUE ENGINEERING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 145 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 146 EUROPE: TISSUE ENGINEERING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
9.3 SPECIALTY CENTERS & CLINICS
9.3.1 GOVERNMENT SUPPORT AND INITIATIVES TO PROPEL MARKET
TABLE 150 TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 151 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 EUROPE: TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 154 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR SPECIALTY CENTERS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
9.4 AMBULATORY SURGERY CENTERS
9.4.1 GROWING DEMAND FOR CONVENIENT AND HIGH-QUALITY CARE TO SUPPORT MARKET GROWTH
TABLE 156 TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 157 NORTH AMERICA: TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 EUROPE: TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 ASIA PACIFIC: TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 LATIN AMERICA: TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION)
10 TISSUE ENGINEERING MARKET, BY REGION (Page No. - 174)
10.1 INTRODUCTION
TABLE 162 TISSUE ENGINEERING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: TISSUE ENGINEERING MARKET SNAPSHOT
TABLE 163 NORTH AMERICA: TISSUE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 NORTH AMERICA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 165 NORTH AMERICA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 NORTH AMERICA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 NORTH AMERICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 169 NORTH AMERICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 170 NORTH AMERICA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing focus on research in biopharmaceutical field to support market growth
TABLE 171 US: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 172 US: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 US: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 US: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 US: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 176 US: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 177 US: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising investments in R&D to propel market
TABLE 178 CANADA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 179 CANADA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 CANADA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 CANADA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CANADA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 183 CANADA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 184 CANADA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 RECESSION IMPACT ON NORTH AMERICAN TISSUE ENGINEERING MARKET
10.3 EUROPE
TABLE 185 EUROPE: TISSUE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 186 EUROPE: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 187 EUROPE: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 EUROPE: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 EUROPE: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 EUROPE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 191 EUROPE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 192 EUROPE: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 UK
10.3.1.1 Increasing adoption of advanced technologies to drive market
TABLE 193 UK: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 194 UK: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 UK: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 UK: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 UK: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 198 UK: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 UK: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Rising strategic alliances between industry leaders to support market growth
TABLE 200 GERMANY: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 201 GERMANY: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 GERMANY: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 GERMANY: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 GERMANY: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 205 GERMANY: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 206 GERMANY: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Growing focus on R&D activities related to stem cell products to drive market
TABLE 207 FRANCE: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 208 FRANCE: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 FRANCE: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 FRANCE: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 FRANCE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 212 FRANCE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 213 FRANCE: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing focus on cell biology research to propel market
TABLE 214 ITALY: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 215 ITALY: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 216 ITALY: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 ITALY: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 ITALY: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 219 ITALY: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 220 ITALY: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing R&D activities and investments across biopharmaceutical industry to support market growth
TABLE 221 SPAIN: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 222 SPAIN: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 223 SPAIN: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 224 SPAIN: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 SPAIN: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 226 SPAIN: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 227 SPAIN: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 228 REST OF EUROPE: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 229 REST OF EUROPE: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 230 REST OF EUROPE: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 REST OF EUROPE: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 REST OF EUROPE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 233 REST OF EUROPE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 234 REST OF EUROPE: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 RECESSION IMPACT ON EUROPEAN TISSUE ENGINEERING MARKET
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: TISSUE ENGINEERING MARKET SNAPSHOT
TABLE 235 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 236 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 237 ASIA PACIFIC: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 238 ASIA PACIFIC: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 ASIA PACIFIC: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 241 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growing support by regulatory bodies for development of advanced solutions to drive market
TABLE 243 JAPAN: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 244 JAPAN: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 245 JAPAN: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 246 JAPAN: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 JAPAN: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 248 JAPAN: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 JAPAN: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing demand for innovative treatment solutions to propel market
TABLE 250 CHINA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 251 CHINA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 CHINA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 CHINA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 CHINA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 255 CHINA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 256 CHINA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing demand for advanced treatment solutions to support market growth
TABLE 257 INDIA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 258 INDIA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 INDIA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 INDIA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 INDIA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 262 INDIA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 263 INDIA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Strong government regulations related to regenerative medicine to drive market
TABLE 264 SOUTH KOREA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 265 SOUTH KOREA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 SOUTH KOREA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 267 SOUTH KOREA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 SOUTH KOREA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 269 SOUTH KOREA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 270 SOUTH KOREA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 271 REST OF ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 272 REST OF ASIA PACIFIC: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 REST OF ASIA PACIFIC: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 274 REST OF ASIA PACIFIC: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 275 REST OF ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.6 RECESSION IMPACT ON ASIA PACIFIC TISSUE ENGINEERING MARKET
10.5 LATIN AMERICA
TABLE 278 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 279 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 280 LATIN AMERICA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 281 LATIN AMERICA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 LATIN AMERICA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 284 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 285 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Increase in pharmaceutical R&D to support market growth
TABLE 286 BRAZIL: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 287 BRAZIL: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 288 BRAZIL: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 289 BRAZIL: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 BRAZIL: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 291 BRAZIL: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 292 BRAZIL: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increased demand for regenerative therapies to propel market
TABLE 293 MEXICO: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 294 MEXICO: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 295 MEXICO: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 296 MEXICO: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 MEXICO: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 298 MEXICO: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 299 MEXICO: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 300 REST OF LATIN AMERICA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 301 REST OF LATIN AMERICA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 REST OF LATIN AMERICA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 303 REST OF LATIN AMERICA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 304 REST OF LATIN AMERICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 305 REST OF LATIN AMERICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 306 REST OF LATIN AMERICA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 RECESSION IMPACT ON LATIN AMERICAN TISSUE ENGINEERING MARKET
10.6 MIDDLE EAST & AFRICA
TABLE 307 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 MIDDLE EAST & AFRICA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 MIDDLE EAST & AFRICA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 313 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 314 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.1 MIDDLE EAST
10.6.1.1 Increased government investments in biomedical research to drive market
TABLE 315 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 316 MIDDLE EAST: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 317 MIDDLE EAST: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 MIDDLE EAST: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 320 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 321 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 AFRICA
10.6.2.1 Need for advanced regenerative medicine to support market growth
TABLE 322 AFRICA: TISSUE ENGINEERING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 323 AFRICA: TISSUE ENGINEERING SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 324 AFRICA: BIOLOGICAL SCAFFOLDS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 325 AFRICA: TISSUE ENGINEERING GRAFTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 AFRICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2021–2028 (USD MILLION)
TABLE 327 AFRICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 328 AFRICA: TISSUE ENGINEERING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.3 RECESSION IMPACT ON MIDDLE EAST & AFRICAN TISSUE ENGINEERING MARKET
11 COMPETITIVE LANDSCAPE (Page No. - 265)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 29 TISSUE ENGINEERING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN TISSUE ENGINEERING MARKET, 2018–2022 (USD MILLION)
11.4 MARKET SHARE ANALYSIS
FIGURE 31 TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 329 TISSUE ENGINEERING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 TISSUE ENGINEERING MARKET: COMPANY EVALUATION MATRIX, 2022
11.5.5 COMPANY FOOTPRINT
TABLE 330 OVERALL COMPANY FOOTPRINT
TABLE 331 PRODUCT FOOTPRINT
TABLE 332 REGIONAL FOOTPRINT
11.6 STARTUP/SME EVALUATION MATRIX
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 33 TISSUE ENGINEERING MARKET: STARTUP/SME EVALUATION MATRIX (2022)
11.7 COMPETITIVE BENCHMARKING
TABLE 333 TISSUE ENGINEERING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 334 TISSUE ENGINEERING MARKET: PRODUCT & REGIONAL FOOTPRINT OF KEY STARTUPS/SMES
11.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 335 TISSUE ENGINEERING MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020−NOVEMBER 2023
TABLE 336 TISSUE ENGINEERING MARKET: KEY DEALS, JANUARY 2020− NOVEMBER 2023
TABLE 337 TISSUE ENGINEERING MARKET: OTHER DEVELOPMENTS, JANUARY 2020−NOVEMBER 2023
12 COMPANY PROFILES (Page No. - 281)
12.1 MAJOR PLAYERS
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
12.1.1 ORGANOGENESIS INC.
TABLE 338 ORGANOGENESIS INC.: BUSINESS OVERVIEW
FIGURE 34 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2022)
12.1.2 INTEGRA LIFESCIENCES
TABLE 339 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 35 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2022)
12.1.3 ABBVIE INC.
TABLE 340 ABBVIE INC.: BUSINESS OVERVIEW
FIGURE 36 ABBVIE INC.: COMPANY SNAPSHOT (2022)
12.1.4 MIMEDX GROUP, INC.
TABLE 341 MIMEDX GROUP, INC.: BUSINESS OVERVIEW
FIGURE 37 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2022)
12.1.5 JOHNSON & JOHNSON SERVICES, INC.
TABLE 342 JOHNSON & JOHNSON SERVICES, INC.: BUSINESS OVERVIEW
FIGURE 38 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2022)
12.1.6 SMITH & NEPHEW PLC
TABLE 343 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 39 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022)
12.1.7 BAXTER
TABLE 344 BAXTER: BUSINESS OVERVIEW
FIGURE 40 BAXTER: COMPANY SNAPSHOT (2022)
12.1.8 BD
TABLE 345 BD: BUSINESS OVERVIEW
FIGURE 41 BD: COMPANY SNAPSHOT (2023)
12.1.9 B. BRAUN SE
TABLE 346 B. BRAUN SE: BUSINESS OVERVIEW
FIGURE 42 B. BRAUN SE: COMPANY SNAPSHOT (2022)
12.1.10 TEIJIN LIMITED
TABLE 347 TEIJIN LIMITED: BUSINESS OVERVIEW
FIGURE 43 TEIJIN LIMITED: COMPANY SNAPSHOT (2022)
12.1.11 INSTITUT STRAUMANN AG
TABLE 348 INSTITUT STRAUMANN AG: BUSINESS OVERVIEW
FIGURE 44 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2022)
12.1.12 MEDTRONIC
TABLE 349 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 45 MEDTRONIC: COMPANY SNAPSHOT (2023)
12.1.13 NUVASIVE, INC.
TABLE 350 NUVASIVE, INC.: BUSINESS OVERVIEW
FIGURE 46 NUVASIVE, INC.: COMPANY SNAPSHOT (2022)
12.1.14 STRYKER
TABLE 351 STRYKER: BUSINESS OVERVIEW
FIGURE 47 STRYKER: COMPANY SNAPSHOT (2022)
12.1.15 TERUMO CORPORATION
TABLE 352 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 48 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
12.1.16 W. L. GORE & ASSOCIATES, INC.
TABLE 353 W. L. GORE & ASSOCIATES, INC.: BUSINESS OVERVIEW
12.1.17 ZIMMER BIOMET
TABLE 354 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 49 ZIMMER BIOMET: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 BIOTISSUE
TABLE 355 BIOTISSUE: COMPANY OVERVIEW
12.2.2 COLLPLANT BIOTECHNOLOGIES LTD.
TABLE 356 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
12.2.3 SUMITOMO PHARMA CO., LTD.
TABLE 357 SUMITOMO PHARMA CO., LTD.: COMPANY OVERVIEW
12.2.4 MATRICEL GMBH
TABLE 358 MATRICEL GMBH: COMPANY OVERVIEW
12.2.5 MALLINCKRODT
TABLE 359 MALLINCKRODT: COMPANY OVERVIEW
12.2.6 REGROW BIOSCIENCES PVT. LTD.
TABLE 360 REGROW BIOSCIENCES PVT. LTD.: COMPANY OVERVIEW
12.2.7 VERICEL CORPORATION
TABLE 361 VERICEL CORPORATION: COMPANY OVERVIEW
12.2.8 TECNOSS S.R.L.
TABLE 362 TECNOSS S.R.L.: COMPANY OVERVIEW
12.2.9 TEGOSCIENCE
TABLE 363 TEGOSCIENCE: COMPANY OVERVIEW
12.2.10 TISSUE REGENIX
TABLE 364 TISSUE REGENIX: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 351)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global tissue engineering market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the tissue engineering market. The secondary sources used for this study include the National Institute of Environmental Health Sciences (NIH), US Food and Drug Administration (FDA), the Center for Disease Control and Prevention (CDC), Organ Procurement & Transplantation Network (OPTN), the U.S. Department of Health & Human Services, Mayo Foundation for Medical Education and Research (MFMER), Commonwealth of Australia Department of Health and Aged Care, International Organization for Standardization (ISO), Stemaid Institute Baja California, Alzheimer’s Association, Statista, annual reports, press releases, investor presentations, and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global tissue engineering market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as ambulatory surgical centers, hospitals, specialty clinics, and transplant centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the tissue engineering market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the tissue engineering business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Tissue engineering is a multidisciplinary field that combines various principles from life sciences and engineering to develop functional biological tissues for medical applications. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. The scope of the report includes FDA-approved tissue-engineered products that contain engineered human cells or tissues and have properties for the regeneration, repair, or replacement of tissue where the new tissue or cells are intended to restore or improve the function of the recipient’s/patient’s organ or tissue.
Stakeholders
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Healthcare Service Providers (Including Hospitals and Ambulatory Care Service Providers)
- Contract Development and Manufacturing Organizations
- Market Research & Consulting Firms
- Venture Capitalists & Investors
- Government Associations
- Academic & Research Institutes
Report Objectives
- To define, describe, and forecast the global tissue engineering market based on application, material, product type, end user, and region.
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall tissue engineering market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as acquisitions, agreements, collaborations, product launches, expansions, and R&D activities in the tissue engineering market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Segment Analysis
- Further breakdown of the other applications segments as per the product applications.
- Further breakdown of the other products as per the product portfolio of prominent players operating in the market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- Further breakdown of the Rest of European tissue engineering market into countries
- Further breakdown of the Rest of Asia Pacific tissue engineering market into countries
- Further breakdown of the Rest of Latin American tissue engineering market into countries
Growth opportunities and latent adjacency in Tissue Engineering Market